Chris van Ingen, Tim Harkness, Heiner Dreismann, Laurence McCarthy, Stuart Auerbach, Tarif Awad | GenomeWeb
Agilent Technologies last week said that Chris van Ingen, president of the Bio-Analytical Measurement business, will retire on Oct. 31, the last day of Agilent's fiscal year.
 
Van Ingen, 61, is a 30-year veteran of Agilent and Hewlett-Packard, which spun off Agilent in November 1999. He was appointed to his current position in May 2001.
 
Agilent did not say who will run the Bio-Analytical Measurement business beginning Nov. 1.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.